Last participant has completed last visit in a five-year prevention trial with Diamyd®

Diamyd Medical today announced that the last participant has made its last visit after five years in a trial in which the diabetes vaccine Diamyd® is being tested as a treatment to delay or prevent that children at high risk for type 1 diabetes is presented with the disease. Results from the trial will be presented by Associate Professor, MD, Helena Elding Larsson, Principal Investigator and sponsor of the study, at the diabetes conference American Diabetes Association (ADA), to be held in San Diego in June, 2017.All visits now performed, extensive laboratory data will be compiled before